The short version of fatty acid oxidation fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
=== Organizations === In response to Verification for Organizations, various news organizations—including The New York Times, Los Angeles Times, The Washington Post, BuzzFeed News, HuffPost, Politico, and Vox Media sites—stated that they would not pay for Twitter verification for their employees. CNN said that it would not pay for employee verification status except for some staff members. The White House has no intentions to pay for checkmarks for their employees, according to Axios. The Twitter account for Amazon Prime Video in the United Kingdom posted a meme of The Boys character Homelander pushing his son off a roof, with Homelander labeled as Twitter and his son labeled as a blue checkmark. Law blog SCOTUSblog stopped posting on Twitter entirely after it lost its checkmark.
== Recording == The recording of Dirt began in the spring of 1992. Producer Dave Jerden, who had previously worked with the band on their debut, Facelift, wanted to work with them again. He admired Layne Staley's lyrics and voice, and Jerry Cantrell's guitar riffs. The track "Would?" produced, engineered, and mixed by Rick Parashar, was recorded before the album, and first appeared on the soundtrack to the 1992 movie Singles. Dirt was recorded at Eldorado Recording Studios in Burbank, London Bridge Studio in Seattle, and One on One Studios in Los Angeles from April to July 1992. Dirt was recorded during the Los Angeles riots that erupted following the acquittal of four LAPD officers caught on camera beating unarmed black motorist Rodney King. The riots started on the first day of recording. The band was watching television when the verdict for the incident was announced. Jerry Cantrell was in a store buying some beer when a man came in and started looting the place. Cantrell also got stuck in traffic and saw people pulling each other out of their cars and beating them. The band tried to get out of Los Angeles without getting hurt while residents were protesting against police brutality. They took Slayer vocalist Tom Araya with them and went to the Joshua Tree desert for four or five days until things calmed down, then moved back into the studio and started recording the album. While recording the album, Staley, who had previously checked out of rehab, quickly went back to using heroin. Staley later went cold-turkey on his own while reading The Bad Place by Dean Koontz.
Stigmata (Ancient Greek: στίγματα, plural of στίγμα stigma, 'mark, spot, brand'), in Roman Catholicism, are bodily wounds, scars and pain which appear in locations corresponding to the crucifixion wounds of Jesus Christ: the hands, wrists, feet, near the heart, the head (from the crown of thorns), and back (from carrying the cross and scourging). St. Francis of Assisi is widely considered the first recorded stigmatic. For over fifty years, St. Padre Pio of Pietrelcina of the Order of Friars Minor Capuchin reported stigmata which were studied by several 20th-century physicians. Stigmatics are primarily a Roman Catholic phenomenon; the Eastern Orthodox Church professes no official view on them. A high percentage (probably over 80%) of all stigmatics are women. In his book Stigmata: A Medieval Phenomenon in a Modern Age, Ted Harrison suggests that there is no single mechanism whereby the marks of stigmata were produced. What is important is that the marks are recognised by others as being of religious significance. Most cases of stigmata have been the result of trickery and fraud. Some cases have also included reportings of a mysterious chalice in visions being given to stigmatics to drink from or the feeling of a sharp sword being driven into one's chest.
According to the Big Bang theory, stable isotopes of the lightest three elements (H, He, and traces of Li) were produced very shortly after the emergence of the universe, in a process called Big Bang nucleosynthesis. These lightest stable nuclides (including deuterium) survive to today, but any radioactive isotopes of the light elements produced in the Big Bang (such as tritium) have long since decayed. Isotopes of elements heavier than boron were not produced at all in the Big Bang, and these first five elements do not have any long-lived radioisotopes. Thus, all radioactive nuclei are, therefore, relatively young with respect to the birth of the universe, having formed later in various other types of nucleosynthesis in stars (in particular, supernovae), and also during ongoing interactions between stable isotopes and energetic particles. For example, carbon-14, a radioactive nuclide with a half-life of only 5700(30) years, is constantly produced in Earth's upper atmosphere due to interactions between cosmic rays and nitrogen. Nuclides that are produced by radioactive decay are called radiogenic nuclides, whether they themselves are stable or not. There exist stable radiogenic nuclides that were formed from short-lived extinct radionuclides in the early Solar System. The extra presence of these stable radiogenic nuclides (such as xenon-129 from extinct iodine-129) against the background of primordial stable nuclides can be inferred by various means.
Sources: en.wikipedia.org
Lewis Goldsmith journalist and political writer Carl Gombrich author of numerous scholarly monographs, academic papers and articles on mysticism, epistemology, ontology, dialectics and music; former opera singer and co-founder of the London Interdisciplinary School; grandson of Ernst Gombrich; son of Sacred Sanskrit and Pali Literature scholar, Richard Gombrich. Ernst Gombrich art historian of Viennese Jewish origin. Richard Gombrich writer of Viennese Jewish ancestry, British Indologist and scholar of Sanskrit, Pāli, and Buddhist studies; historian of Tripiṭaka, Sthavira nikāya, Mahāsāṃghika schools, Abhidharma, Vinaya, Theravada, and ancient collections of Buddhist texts David Graeber British-American author, academic, scholar and anti capitalist anarchist activist, writer of Ashkenazi origin. Linda Grant FRSL (born 15 February 1951) is an English novelist and journalist. She published her first book, a non-fiction work, Sexing the Millennium: A Political History of the Sexual Revolution, in 1993. She wrote a personal memoir of her mother's fight with vascular dementia called Remind Me Who I Am, Again, which was cited in a discussion about ageing on BBC Radio 4's Thinking Allowed in December 2003. Dominic Green (born 1970) is a British historian, columnist and musician. A Fellow of the Royal Historical Society and the Royal Society of Arts, he is editor of the US edition of The Spectator[dead link] and a commissioning editor of The Critic.[failed verification] He is a columnist and film reviewer for The Spectator, and a columnist for The Daily Telegraph.
== Honors and awards == Diamandis is a member of the Academy of Athens and the Royal Society of Canada. He is also a fellow of the American Association for the Advancement of Science, the Canadian Academy of Health Sciences, and the Royal College of Physicians and Surgeons of Canada. From the American Association for Clinical Chemistry, he has received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics, among other awards; he is also a member of the Association's Hall of Fame.
Isotonitazepyne (N-pyrrolidino-isotonitazene, NPI) is a benzimidazole derivative with potent opioid effects, which has been sold as a designer drug over the internet. Its in vitro potency is approximately 1000 times that of morphine. One sample of counterfeit oxycodone pills were found to contain between 3.3 and 3.5 mg of NPI per pill and no oxycodone.
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.